AIRLINK 176.88 Decreased By ▼ -1.04 (-0.58%)
BOP 12.96 Increased By ▲ 0.08 (0.62%)
CNERGY 7.58 No Change ▼ 0.00 (0%)
FCCL 45.55 Decreased By ▼ -0.44 (-0.96%)
FFL 15.10 Decreased By ▼ -0.06 (-0.4%)
FLYNG 27.70 Increased By ▲ 0.36 (1.32%)
HUBC 131.64 Decreased By ▼ -0.40 (-0.3%)
HUMNL 13.30 Increased By ▲ 0.01 (0.08%)
KEL 4.55 Increased By ▲ 0.09 (2.02%)
KOSM 6.05 Decreased By ▼ -0.01 (-0.17%)
MLCF 57.95 Increased By ▲ 1.32 (2.33%)
OGDC 216.99 Decreased By ▼ -6.85 (-3.06%)
PACE 5.96 Decreased By ▼ -0.03 (-0.5%)
PAEL 41.30 Decreased By ▼ -0.21 (-0.51%)
PIAHCLA 16.10 Increased By ▲ 0.09 (0.56%)
PIBTL 9.80 Decreased By ▼ -0.08 (-0.81%)
POWER 11.38 Increased By ▲ 0.22 (1.97%)
PPL 183.75 Decreased By ▼ -2.88 (-1.54%)
PRL 34.59 Decreased By ▼ -0.31 (-0.89%)
PTC 23.35 Decreased By ▼ -0.18 (-0.76%)
SEARL 95.40 Increased By ▲ 0.44 (0.46%)
SILK 1.15 Increased By ▲ 0.01 (0.88%)
SSGC 35.47 Decreased By ▼ -0.03 (-0.08%)
SYM 15.78 Increased By ▲ 0.14 (0.9%)
TELE 7.90 Increased By ▲ 0.03 (0.38%)
TPLP 11.00 Increased By ▲ 0.07 (0.64%)
TRG 58.95 Decreased By ▼ -0.25 (-0.42%)
WAVESAPP 10.80 Increased By ▲ 0.02 (0.19%)
WTL 1.35 No Change ▼ 0.00 (0%)
YOUW 3.84 Increased By ▲ 0.04 (1.05%)
AIRLINK 176.88 Decreased By ▼ -1.04 (-0.58%)
BOP 12.96 Increased By ▲ 0.08 (0.62%)
CNERGY 7.58 No Change ▼ 0.00 (0%)
FCCL 45.55 Decreased By ▼ -0.44 (-0.96%)
FFL 15.10 Decreased By ▼ -0.06 (-0.4%)
FLYNG 27.70 Increased By ▲ 0.36 (1.32%)
HUBC 131.64 Decreased By ▼ -0.40 (-0.3%)
HUMNL 13.30 Increased By ▲ 0.01 (0.08%)
KEL 4.55 Increased By ▲ 0.09 (2.02%)
KOSM 6.05 Decreased By ▼ -0.01 (-0.17%)
MLCF 57.95 Increased By ▲ 1.32 (2.33%)
OGDC 216.99 Decreased By ▼ -6.85 (-3.06%)
PACE 5.96 Decreased By ▼ -0.03 (-0.5%)
PAEL 41.30 Decreased By ▼ -0.21 (-0.51%)
PIAHCLA 16.10 Increased By ▲ 0.09 (0.56%)
PIBTL 9.80 Decreased By ▼ -0.08 (-0.81%)
POWER 11.38 Increased By ▲ 0.22 (1.97%)
PPL 183.75 Decreased By ▼ -2.88 (-1.54%)
PRL 34.59 Decreased By ▼ -0.31 (-0.89%)
PTC 23.35 Decreased By ▼ -0.18 (-0.76%)
SEARL 95.40 Increased By ▲ 0.44 (0.46%)
SILK 1.15 Increased By ▲ 0.01 (0.88%)
SSGC 35.47 Decreased By ▼ -0.03 (-0.08%)
SYM 15.78 Increased By ▲ 0.14 (0.9%)
TELE 7.90 Increased By ▲ 0.03 (0.38%)
TPLP 11.00 Increased By ▲ 0.07 (0.64%)
TRG 58.95 Decreased By ▼ -0.25 (-0.42%)
WAVESAPP 10.80 Increased By ▲ 0.02 (0.19%)
WTL 1.35 No Change ▼ 0.00 (0%)
YOUW 3.84 Increased By ▲ 0.04 (1.05%)
BR100 12,108 Decreased By -21.7 (-0.18%)
BR30 36,902 Decreased By -343 (-0.92%)
KSE100 114,811 Increased By 412.7 (0.36%)
KSE30 35,503 Increased By 44.8 (0.13%)
World

Hungary in talks to plug expected shortfall in COVID-19 vaccine deliveries

  • "Inoculations require vaccines and we know that another one of the shots ordered by Brussels will be missing, the (Johnson & Johnson) vaccine will not arrive. That means half a million fewer shots," Gergely Gulyas told an online briefing.
  • The EMA, the EU's regulator, says it continues to believe the benefits of the vaccines far outweigh the risks of side effects.
Published April 15, 2021

BUDAPEST: Hungary's government is in talks with all possible suppliers to make up for an expected shortfall of half a million vaccine doses against COVID-19, Prime Minister Viktor Orban's chief of staff said on Thursday.

Hungary has been at the forefront of the European Union's inoculation drive, while its death rates have also been among the highest in the world. As of Thursday, it had vaccinated 3.1 million people, or nearly a third of its population.

"Inoculations require vaccines and we know that another one of the shots ordered by Brussels will be missing, the (Johnson & Johnson) vaccine will not arrive. That means half a million fewer shots," Gergely Gulyas told an online briefing.

The European Medicines Agency is expected to issue a recommendation next week on use of Johnson & Johnson's COVID-19 vaccine, following reports of rare blood clots similar to those reported for the AstraZeneca shot.

The EMA, the EU's regulator, says it continues to believe the benefits of the vaccines far outweigh the risks of side effects.

Gulyas said all shots used in Hungary, including those of AstraZeneca and China's Sinopharm, were safe and effective. He was responding to local media reports that some people had still fallen ill or were not sufficiently immunised after being inoculated with the Chinese vaccine.

Hungary, with a population around 10 million, has so far recorded 736,982 COVID-19 infections and 24,521 deaths. Nearly 10,000 patients are currently in hospitals, more than 1,100 of them on ventilators, which is pressuring the healthcare system.

"If we can make up for the shortfall in Johnson & Johnson shots, then we can inoculate everyone (registered) by the end of May, then we will have more vaccines than the number of people registered," Gulyas said.

With daily deaths still around record highs, Orban is having to strike a balance between curbing the spread of the virus and minimising the economic damage of lockdown restrictions. He announced further moderate easing steps on Wednesday.

Comments

Comments are closed.